Chordia Therapeutics Inc. (hereinafter referred to as the "Company") considers it as one of its corporate social responsibilities to ensure that the personal information it deals with shall be handled safely and fairly in compliance with laws and regulations, guidelines established by the government and other norms regarding the handling of personal information, and as such the Company shall handle the personal information appropriately in accordance with the following basic policies.
The Company shall comply with the laws and regulations, guidelines and other norms applicable to personal information.
The Company shall acquire personal information by lawful and fair means.
The Company shall use personal information for the following purposes. It shall be used within the scope of the purposes of use, provided that the specified personal information shall be handled in compliance with the scope of the purposes of use subject to having been managed appropriately in accordance with the Company's internal rules.
(1) Purposes of use of personal information regarding the Company's shareholders
- Exercise of rights and fulfillment of obligations under the Companies Act
- Provision of various benefits by the Company to shareholders by virtue of the status as such
- Implementation of various measures to facilitate forwarding services from the standpoints of a member of association and of an association.
- Shareholder management, including the preparation of shareholder data based on certain standards pursuant to all types of laws and regulations
- Communication regarding and response to inquiries
(2) Purposes of use of personal information regarding persons whose personal information is acquired through IR activities
- Timely, fair and continuous provision of information necessary for investment decision
- Communication regarding and response to inquiries
(3) Purposes of use of personal information regarding healthcare professionals (e.g., doctors, dentists, pharmacists, etc.)
- Provision, collection and review of information regarding appropriate use of medicinal products, etc.
- Identification of parties who use medicinal products, etc. and those to whom medicinal products, etc. are sold.
- Requests for and conduct and support of clinical studies, post-marketing surveillance or clinical research on medicinal products, etc.
- Provision, collection and review of information in medical and pharmaceutical areas
- Surveillance activities and research in medical and pharmaceutical areas
- Notifications, etc. to relevant authorities under laws and regulations on securing the quality, efficacy and safety of products, including medicinal products and medical devices
- Communication relating to all inquiries about the Company's products
- Congratulations, condolences, season's greetings, etc.
- Implementation of business communications and correspondence
(4) Purposes of use of personal information regarding customers, consumers and patients
- Communication regarding and response to consultations about medicinal products, etc.
- Response to and surveillance of adverse reactions to medicinal products, etc.
- Provision of information and after-sale service for medicinal products, etc.
- Communication with manufacturing and selling operators, manufacturers, and sellers of medicinal products, etc., and healthcare professionals, etc.
- Notifications, etc. to relevant authorities under laws and regulations
- Control of entry to and exit and from the Company's facilities
- Congratulations, condolences, season's greetings, etc.
(5) Purposes of use of personal information regarding applicants for employment with the Company
- Employment screening, notifications regarding employment screening, etc. as well as personnel and labor management, etc. after hiring decisions
(6) Purposes of use of personal information regarding persons who use an information desk for inquiries about the Company
- Communication regarding and response to inquiries about the Company
- Statistical analysis for the state of use for the maintenance and management of the Company's website and the provision of better services
(7) Purposes of use of personal information regarding experts and licensed persons in various areas
- Appointment of contractors specializing in legal services and intellectual property services
- Appointment of contractors specializing medical, pharmaceutical, chemical and food services and health services
- Appointment of contractors specializing in accounting and taxation services
- Appointment of contractors specializing in business management services
- Congratulations, condolences, season's greetings, etc.
(8) Purposes of use of personal information regarding persons who belong to a party or prospective party with whom the Company has, or shall enter into, a contract
- Smooth fulfillment of business between the Company and such party
- Notification to a party with whom the Company has a contract
- Congratulations, condolences, season's greetings, etc.
(9) Purposes of use of personal information regarding persons who belong to the Company
- Directors
- Management of schedules, payment of remuneration, etc., identification, welfare, and safety and health, etc.
- Notification and reporting to public authorities, etc.
- Smooth fulfillment of work for the Company's business
- Employees
- Management of attendance, payment of salaries and allowances, etc., identification, personnel affairs, assessment, capability development, welfare, and safety and health, etc.
- Notification and reporting to public authorities, etc.
- Smooth fulfillment of work for the Company's business
- Support for the provision of information regarding the appropriate use of medicinal products, etc.
- Support for the development of medicinal products, etc.
- Support for the post-marketing surveillance of medicinal products, etc.
- Family of employees
- Contact for emergencies
- Calculation and payment of salaries, allowances, etc. to employees
- Welfare management
- Ex-employees
- Procedures and communication after end of employment
(10) Purposes of use of personal information acquired in relation to the research activities of the Company
- Utilization of the base sequence, which is considered to be an individual identification code, acquired from a commercially available human-derived cultured cell strain or human-derived cell strain or a human-derived specimen of a subject obtained through a clinical study and disease-related information, etc. for drug-discovery research or academic research
- Utilization of the base sequence, which is considered to be an individual identification code, acquired from a human-derived specimen, etc. obtained from a joint research institute and disease-related information, etc. for drug-discovery research or academic research
(11) Purposes of use of personal information acquired in relation to the Company's development activities
- Utilization of the base sequence, which is considered to be an individual identification code, acquired from a human-derived specimen, etc. of a subject obtained through clinical studies and disease-related information, etc. for analysis/assessment for appropriate drug discovery, appropriate use, etc. or academic research
(12) Purposes of use of personal information stored in information systems used by the Company
- Analysis of data, including personal information stored in the information system used by the Company, to prevent, detect and likewise deal with any misconduct within and outside the Company
The Company shall not disclose or provide any personal information to third parties without consent of the subject of such personal information, except:
(1) if required by laws and regulations;
(2) if necessary to protect the life, limb or property of any person;
(3) if specifically necessary to promote the improvement of public health or the healthy development of children;
(4) if necessary to cooperate with government bodies or local public authorities or any person entrusted thereby in fulfilling their duties required by the laws and regulations;
(5) for outsourcing, business succession or joint use; or
(6) if otherwise exceptionally pursuant to the Personal Information Protection Act.
If requested by the relevant person to disclose, correct, add to or delete, or suspend the use of personal data held by the Company, the Company shall respond to such request within a reasonable period of time and a reasonable scope in accordance with its rules.
To prevent any personal information from being divulged, lost or destroyed and to manage personal information appropriately, the Company shall clarify employees’ responsibilities, develop internal rules, educate and train employees, and take physical and/or technological measures and other safety management measures to prevent the divulgence of personal information or other incidents. For specific details of these safety management measures, please contact the Company’s information desk.
The Company shall accept all opinions, questions, complaints or other inquiries regarding the handling of personal information, etc. via its inquiry form. The Company shall appropriately, in good faith and promptly respond to any inquiry, complaint, etc. about the personal information received by a relevant information desk.
Date of enactment: December 11, 2020
Date of last amendment: July 12, 2022 (This amendment shall be retroactively applied from April 1, 2022.)
Chordia Therapeutics Inc. Hiroshi Miyake, CEO
